Advertisement

Endocrine

, Volume 46, Issue 1, pp 123–130 | Cite as

Kelp use in patients with thyroid cancer

  • Jennifer E. RosenEmail author
  • Paula Gardiner
  • Robert B. Saper
  • Elizabeth N. Pearce
  • Kallista Hammer
  • Rebecca L. Gupta-Lawrence
  • Stephanie L. Lee
Original Article

Abstract

To report on the incidence and use of kelp among patients with thyroid cancer. Data were collected using a web-based online anonymous survey under Institutional Review Board approval from Boston University. This report is based on 27 responses from subjects with thyroid cancer who use kelp. Demographic factors and complementary and alternative use were included. Respondents were primarily over age 40, white, female and have at least a high school education. The top five modalities were multivitamins, special diets, herbal supplements, prayer for health reasons and herbal tea. Only one patient reported perceiving a particular modality had a negative effect on treatment. Complementary and alternative medicine (CAM) was more often perceived as being used to aid their thyroid cancer treatment than to help with symptoms. On average, respondents who use kelp also use at least 11 additional CAM modalities. Only 1/2 of respondents who use kelp reported telling their physicians about their CAM use, and nearly 1/3 of respondents reported their CAM use was neither known, prescribed nor asked about by their physicians. In comparison to both national surveys of the general US population and patients with thyroid cancer, kelp users with thyroid cancer use at least twice the number of additional CAM therapies and report their use far less often. Physicians who treat patients with thyroid cancer should be aware of these data to further assist in their assessment and care.

Keywords

Kelp Thyroid cancer Complementary medicine 

List of Abbreviations

IRB

Institutional Review Board

CAM

Complementary and alternative medicine

US

United States

NCCAM

National Center for Complementary and Alternative Medicine

μg

Micrograms

TSH

Thyroid-stimulating hormone

TgAb

Anti-thyroglobulin antibodies

TG

Thyroglobulin

EBRT

External beam radiation therapy

Notes

Conflict interests

The author(s) declare that they have no competing interests.

References

  1. 1.
    National Center for Complementary and Alternative Medicine Herbs at a GlanceGoogle Scholar
  2. 2.
    F.W. Clements, Health significance of endemic goitre and related conditions. Monogr. Ser. World Health Organ. 44, 235–260 (1960)PubMedGoogle Scholar
  3. 3.
    J. Teas, S. Pino, A. Critchley, L.E. Braverman, Variability of iodine content in common commercially available edible seaweeds. Thyroid Off. J. Am. Thyroid Assoc. 14(10), 836–841 (2004). doi: 10.1089/thy.2004.14.836 CrossRefGoogle Scholar
  4. 4.
    Institute of Medicine: Dietary Reference Intakes for Vitamin A, vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. (2001)Google Scholar
  5. 5.
    T. Michikawa, M. Inoue, T. Shimazu, N. Sawada, M. Iwasaki, S. Sasazuki, T. Yamaji, S. Tsugane, Seaweed consumption and the risk of thyroid cancer in women: the Japan Public Health Center-based Prospective Study. Eur. J. Cancer Prev. 21(3), 254–260 (2012). doi: 10.1097/CEJ.0b013e32834a8042 PubMedCrossRefGoogle Scholar
  6. 6.
    S.M. Arum, X. He, L.E. Braverman, Excess iodine from an unexpected source. N. Engl. J. Med. 360(4), 424–426 (2009). doi: 10.1056/NEJMc0807580 PubMedCrossRefGoogle Scholar
  7. 7.
    P. Smyth, G. Cloughley, C. Clarke, D. Smith, E. Burbridge, Iodine and differentiated thyroid cancer: pathogenetic and therapeutic implications. Hormones (Athens) 8(3), 192–198 (2009)CrossRefGoogle Scholar
  8. 8.
    J. Teas, L.E. Braverman, M.S. Kurzer, S. Pino, T.G. Hurley, J.R. Hebert, Seaweed and soy: companion foods in Asian cuisine and their effects on thyroid function in American women. J. Med. Food 10(1), 90–100 (2007). doi: 10.1089/jmf.2005.056 PubMedCrossRefGoogle Scholar
  9. 9.
    B.A. Crawford, C.T. Cowell, P.J. Emder, D.L. Learoyd, E.L. Chua, J. Sinn, M.M. Jack, Iodine toxicity from soy milk and seaweed ingestion is associated with serious thyroid dysfunction. Med. J. Aust. 193(7), 413–415 (2010)PubMedGoogle Scholar
  10. 10.
    B.C. Eliason, Transient hyperthyroidism in a patient taking dietary supplements containing kelp. J. Am. Board Fam. Pract. 11(6), 478–480 (1998)PubMedCrossRefGoogle Scholar
  11. 11.
    R.B. Saper, S.N. Kales, J. Paquin, M.J. Burns, D.M. Eisenberg, R.B. Davis, R.S. Phillips, Heavy metal content of ayurvedic herbal medicine products. J. Am. Med. Assoc. 292(23), 2868–2873 (2004). doi: 10.1001/jama.292.23.2868 CrossRefGoogle Scholar
  12. 12.
    R.B. Saper, R.S. Phillips, A. Sehgal, N. Khouri, R.B. Davis, J. Paquin, V. Thuppil, S.N. Kales, Lead, mercury, and arsenic in US- and Indian-manufactured ayurvedic medicines sold via the internet. JAMA, J. Am. Med. Assoc. 300(8), 915–923 (2008). doi: 10.1001/jama.300.8.915 CrossRefGoogle Scholar
  13. 13.
    A.M. Leung, L.E. Braverman, Iodine-induced thyroid dysfunction. Curr. Opin. Endocrinol. Diabetes Obes. 19(5), 414–419 (2012). doi: 10.1097/MED.0b013e3283565bb2 PubMedCrossRefGoogle Scholar
  14. 14.
    C.D. Clark, B. Bassett, M.R. Burge, Effects of kelp supplementation on thyroid function in euthyroid subjects. Endocr. Pract. 9(5), 363–369 (2003)PubMedCrossRefGoogle Scholar
  15. 15.
    K. Miyai, T. Tokushige, M. Kondo, Suppression of thyroid function during ingestion of seaweed “Kombu” (Laminaria japonoca) in normal Japanese adults. Endocr. J. 55(6), 1103–1108 (2008)PubMedCrossRefGoogle Scholar
  16. 16.
    P.M. Barnes, B. Bloom, R.L. Nahin, Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep 10(12), 1–23 (2008)Google Scholar
  17. 17.
    J.M. Fouladbakhsh, M. Stommel, B.A. Given, C.W. Given, Predictors of use of complementary and alternative therapies among patients with cancer. Oncol. Nurs. Forum 32(6), 1115–1122 (2005). doi: 10.1188/05.ONF.1115-1122 PubMedCrossRefGoogle Scholar
  18. 18.
    B. Cassileth, Gerson regimen. Oncology (Williston Park) 24(2), 201 (2010)Google Scholar
  19. 19.
    H.M. Park, S.Y. Kim, I.C. Jung, Y.W. Lee, C.K. Cho, H.S. Yoo, Integrative tumor board: a case report and discussion from East-West Cancer Center. Integr. Cancer Ther. 9(2), 236–245 (2010). doi: 10.1177/1534735410371479 PubMedCrossRefGoogle Scholar
  20. 20.
    L.W. Corbin, B.K. Mellis, B.L. Beaty, J.S. Kutner, The use of complementary and alternative medicine therapies by patients with advanced cancer and pain in a hospice setting: a multicentered, descriptive study. J. Palliat. Med. 12(1), 7–8 (2009)PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    E. Ben-Arye, M. Frenkel, G. Bar-Sela, R.S. Margalit, D. Hermoni, A. Kuten, Teaching complementary medicine at an academic oncology department. J. Cancer Educ. 23(1), 46–50 (2008). doi: 10.1080/08858190701821261 PubMedCrossRefGoogle Scholar
  22. 22.
    E. Ernst, Massage therapy for cancer palliation and supportive care: a systematic review of randomised clinical trials. Support. Care Cancer 17(4), 333–337 (2009)PubMedCrossRefGoogle Scholar
  23. 23.
    C.L. Carpenter, P.A. Ganz, L. Bernstein, Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res. Treat. 116(2), 387–396 (2009)PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    J. Rosen, P. Gardiner, R.B. Saper, A. Filippelli, L.F. White, E.N. Pearce, R. Gupta-Lawrence, S.L. Lee, Complementary and alternative medicine use among patients with thyroid cancer. Thyroid Off. J. Am. Thyroid Assoc. (2013). doi: 10.1089/thy.2012.0495
  25. 25.
    D.M. Eisenberg, R.C. Kessler, C. Foster, F.E. Norlock, D.R. Calkins, T.L. Delbanco, Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N. Engl. J. Med. 328(4), 246–252 (1993). doi: 10.1056/NEJM199301283280406 PubMedCrossRefGoogle Scholar
  26. 26.
    K. Tasaki, G. Maskarinec, D.M. Shumay, Y. Tatsumura, H. Kakai, Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients’ perspectives. Psycho-Oncology 11(3), 212–220 (2002). doi: 10.1002/pon.552 PubMedCrossRefGoogle Scholar
  27. 27.
    M.H. Cohen, D.M. Eisenberg, Potential physician malpractice liability associated with complementary and integrative medical therapies. Ann. Intern. Med. 136(8), 596–603 (2002)PubMedCrossRefGoogle Scholar
  28. 28.
    K.J. Kemper, A. Amata-Kynvi, L. Dvorkin, J.S. Whelan, A. Woolf, R.C. Samuels, P. Hibberd, Herbs and other dietary supplements: healthcare professionals’ knowledge, attitudes, and practices. Altern. Ther. Health Med. 9(3), 42–49 (2003)PubMedGoogle Scholar
  29. 29.
    D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009). doi: 10.1089/thy.2009.0110 PubMedCrossRefGoogle Scholar
  30. 30.
    N. Konno, H. Makita, K. Yuri, N. Iizuka, K. Kawasaki, Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J. Clin. Endocrinol. Metab. 78(2), 393–397 (1994)PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Jennifer E. Rosen
    • 1
    Email author
  • Paula Gardiner
    • 2
  • Robert B. Saper
    • 2
  • Elizabeth N. Pearce
    • 3
  • Kallista Hammer
    • 1
  • Rebecca L. Gupta-Lawrence
    • 1
  • Stephanie L. Lee
    • 3
  1. 1.Department of SurgeryBoston UniversityBostonUSA
  2. 2.Department of Family MedicineBoston UniversityBostonUSA
  3. 3.Section of Endocrinology, Diabetes, and Nutrition, Department of MedicineBoston University School of MedicineBostonUSA

Personalised recommendations